Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Restaurant Brands International Inc. Common Shares (QSR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Restaurant Brands International Inc. Common Shares — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while Restaurant Brands International Inc. Common Shares trades at $73.03 (market cap $24.77B). The key difference: Restaurant Brands International Inc. Common Shares is far larger — about 4.8× Oruka Therapeutics Inc. Common Stock's market cap, and Restaurant Brands International Inc. Common Shares pays a 3.65% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Restaurant Brands International Inc. Common Shares for 6 Days on average.
| ORKA | QSR | |
|---|---|---|
Market Cap | $5.18B | $24.77B |
Volume | 490,798 | 3,180,422 |
Sector | Health | Consumer Cyclical |
52-Week High | $113.08 | $81.67 |
52-Week Low | $26.19 | $65.69 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $4.31B | $39.38B |
Dividend Yield | — | 3.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
QSR trades at $71.27, up 0.21% on the day, with a bearish technical signal driven by moving averages and oscillators. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $1.08. Revenue reached $9.43B in 2025, with net income of $776M, and is projected to grow to $9.7B in 2026. Analyst consensus is bullish with a price target of $84.80, supported by Burger King's turnaround momentum noted in recent news.
The outlook for QSR is positive due to strong earnings performance and analyst optimism, but near-term technical weakness and competitive pressures pose risks. Investment opportunity lies in execution of the Burger King revitalization and franchise strategy, while risks include market volatility and execution gaps in value offerings against rivals like McDonald's.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Restaurant Brands International Inc. Common Shares
Restaurant Brands International owns and franchises quick-service restaurant brands, including Burger King, Tim Hortons, Popeyes, and Firehouse Subs.
Read more on QSR →
